the EDPS, in collaboration with Almirall, presents the book the patient with digestive symptoms: guided practice of acting diagnóstico-terapéutica.
6Th week of the diseases digestive.
-the book has counted with the participation of more than thirty specialists.
– he made a full tour of the different symptoms and diseases of the digestive tract.
– during the National Congress, held the III Edition of the Symposium the last and most important in Gastroenterology Clinic ”, organized by Almirall.
Seville, June of 2011- the Spanish society of digestive pathology (EDPS), with the collaboration of Almirall, presents the second edition of the book the patient with digestive symptoms: practical guide to diagnóstico-terapéutica performance ”, a complete tour of digestive pathology on the basis of the most relevant symptoms. In this second edition has been an update of all the topics included in the first volume, which together represents the most comprehensive guide to diagnosis and treatment of patients with symptoms digestives.
this manual offers the possibility to find in a single document all developments relating to the diagnóstico-terapéutica performance of patients with different symptoms that fall within the gastrointestinal pathology specialist ”, according to Dr. j. Enrique DomÃnguez MuñozPresident of the Spanish society of digestive pathology and Chief of service device digestive the Hospital ClÃnico Universitario de Santiago Compostela.
almost half of the Spanish population suffers from some sort of gastrointestinal pathology. In this sense, any investment in training and information on digestive health is a vital tool for specialists in gastroenterology.
the book is divided into 19 chapters, each devoted to the main symptoms and pathologies of the digestive disease, in which the specialist will find specific information about each of them. To this end, has counted with the collaboration of more than thirty medical professionals who have contributed their experience, under the coordination of Dr. Dominguez Muñoz.
this new edition, presented within the digestive diseases week VI, SED 2011, the scientific meeting of reference in the field of Gastroenterology with the presence of more than 1,000 experts held in Seville, has a circulation of 10,000 copies and distributed directly to the collective health.
the last and most important in Gastroenterology Clinic ”: symposium of art with the presentation of the book, Almirall will organize, within the framework of the LXX annual Congress of the EDPS, the Symposium III latest and most relevant in Gastroenterology Clinic ”. During this year’s Edition will present the latest advances in the most current issues of digestive pathology, such as acid, functional digestive disorders, inflammatory bowel disease-related diseases and diseases of the biliary tract and pancreas.
the meeting, coordinated by Dr. j. Enrique DomÃnguez Muñoz, will feature the participation of the most prestigious specialists in each of the items to.
Spanish society of digestive pathology (EDPS).
the EDPS is a scientific and professional, non-profit, which is 78 years of existence and currently comprises more than 2,100 medical partners.
is oriented to the promotion and dissemination of research and knowledge in the field of digestive diseases, health promotion and preventive diagnóstico-terapéuticos Basic, epidemiological aspects, as well as the promotion of its practical application, with the aim to be a reference for specialists in digestive system, related specialties and general population, and an ally of the Administration and staff social.
between the end of the EDPS highlights the promote the formation of multicenter and multidisciplinary groups to carry out basic, epidemiological research and clinics in the field of digestive diseases, and maintaining scientific relations and links with similar or related companies, as well as with academic institutions, and any other institution interested in the development of digestive pathology.
Almirall.
Almirall is an international pharmaceutical company based on innovation and committed to the health. With headquarters in Barcelona (Spain), Almirall researches, develops, produces and sells drugs own r & d and licensing with the aim of improving the health and well-being of the people.
the therapeutic areas in which concentrates its resources in research are related to the treatment of asthma, COPD (chronic obstructive pulmonary disease), gastrointestinal disorders, psoriasis and other forms skin.
, the drug from Almirall currently present in over 70 countries. Account with a direct presence in Europe and Latin America through 12 subsidiaries.
